RESTRUCTURING

On an ongoing basis, we review the global economy, the healthcare industry, and the markets in which we compete to identify opportunities for efficiencies, enhance commercial capabilities, align our resources and offer our customers better solutions. In order to realize these opportunities, we undertake restructuring-type activities to transform our business.

On November 1, 2017, we launched a Complexity Reduction Initiative (the "2018 Program"), a company-wide restructuring program designed to improve operational performance and reduce cost, freeing up resources to invest in accelerated growth. This program includes a reduction of headcount and operating costs which will enable a more streamlined organizational structure. We expect to incur aggregate charges between $50 million and $60 million associated with these actions, of which we expect $35 million to $40 million will consist of severance and other employee costs and the remainder will consist of other exit costs, primarily related to third party services. These charges, substantially all of which will result in cash outlays, will be incurred as the specific actions required to execute on these initiatives are identified and approved and are expected to continue through fiscal 2020. During the three and nine months ended December 30, 2017, we incurred $31.7 million of restructuring and turnaround costs under this program.

During fiscal 2017, we launched a restructuring program (the "2017 Program") designed to reposition our organization and improve our cost structure. During the nine months ended December 30, 2017, we incurred $7.7 million of restructuring and turnaround costs under this program. There were no charges recorded during the three months ended December 30, 2017 under this program. During the three and nine months ended December 31, 2016, we incurred $4.1 million and $22.9 million, respectively, of restructuring and turnaround charges under this program. As of December 30, 2017, charges associated with the 2017 Program were substantially complete.

The following table summarizes the activity for restructuring reserves related to the 2018 Program and the 2017 Program for the nine months ended December 30, 2017, substantially all of which relates to employee severance and other employee costs:



(In thousands)	2018 Program			2017 Program			Total
Balance at April 1, 2017	$	—		$	7,468		$	7,468
Costs incurred, net of reversals	28,607			1,055			29,662
Payments	(296		)	(5,405		)	(5,701		)
Balance at December 30, 2017	$	28,311		$	3,118		$	31,429

Restructuring costs for the three months ended December 30, 2017 included as a component of selling, general and administrative expenses and research and development in the accompanying consolidated statements of (loss) income were $24.2 million and $4.3 million, respectively. Restructuring costs for the nine months ended December 30, 2017 included as a component of selling, general and administrative expenses and research and development in the accompanying consolidated statements of (loss) income were $25.1 million and $4.6 million, respectively. As of December 30, 2017, we had a restructuring liability of $31.4 million, of which $24.6 million is payable within the next twelve months.

In addition to the restructuring costs included in the table above, during the three and nine months ended December 30, 2017, we also incurred costs of $2.8 million and $9.9 million, respectively, that do not constitute as restructuring under ASC 420, Exit and Disposal Cost Obligations, which we refer to as turnaround costs. These costs, substantially all of which have been included as a component of selling, general and administrative expenses in the accompanying consolidated statements of (loss) income, consist primarily of expenditures directly related to our restructuring actions and include program management, implementation of outsourcing initiatives and accelerated depreciation.

The tables below present restructuring and turnaround costs by reportable segment:



Restructuring costs	Three Months Ended						Nine Months Ended
(In thousands)	December 30, 2017			December 31, 2016			December 30, 2017			December 31, 2016
Japan	$	52		$	(72	)	$	163		$	764
EMEA	869			198			894			3,209
North America Plasma	555			1			555			369
All Other	26,979			1,905			28,050			13,722
Total	$	28,455		$	2,032		$	29,662		$	18,064

Turnaround costs	Three Months Ended						Nine Months Ended
(In thousands)	December 30, 2017			December 31, 2016			December 30, 2017			December 31, 2016
Japan	$	—		$	—		$	—		$	2
EMEA	(161		)	(5		)	(135		)	76
North America Plasma	229			37			578			973
All Other	2,775			4,674			9,463			8,036
Total	$	2,843		$	4,706		$	9,906		$	9,087

Total restructuring and turnaround costs	$	31,298		$	6,738		$	39,568		$	27,151